Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT01571934
Eligibility Criteria:
Inclusion Criteria:
* Males with mild/moderate hemophilia A (fVIII activity 1-40%)
* Planned surgical intervention which is anticipated to require 5 consecutive days of fVIII replacement therapy (These can be outpatient or inpatient treatment days.)
* Weight \>22.5 kg (To assure that volumes of blood to be drawn for study purposes are safe.)
Exclusion Criteria:
* Past history of an inhibitor (inhibitor titer \>0.4 BU/ml)
* HIV infection with CD4 count \<400/ul
* Currently receiving immunosuppressive medication(s)
* Unable to tolerate quantity of blood to be drawn
* Current or past diagnosis autoimmune disorder
* Current or past diagnosis of immune deficiency disorder other than HIV
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT01571934
Study Brief:
Protocol Section:
NCT01571934